Navigation Links
Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
Date:4/14/2008

- Faster delivery, efficient supply chain, and reduced cost for

pharmaceutical manufacturers

NEW YORK, April 14 /PRNewswire/ -- Sumitomo Corporation of America (SCOA) has reached an agreement with Chiral Quest, Inc., a manufacturer and developer of chiral products using proprietary chiral technologies, for the distribution and sale of chiral products to the pharmaceutical industry.

Effective immediately, Sumitomo will be the exclusive sales agent for Chiral Quest in Japan and selected worldwide accounts.

More than 40 percent of the ethical drugs manufactured today utilize chiral intermediate technology. Chiral chemocatalysts play a key role in the manufacture of medicines, fine chemicals, agricultural chemicals, and flavors and fragrances.

"Chiral Quest is now in an expansion phase, and Sumitomo's international network of marketing and distribution facilities will enable us to provide our specialty chiral molecules quickly to pharmaceutical manufacturers globally at competitive prices," said Dr. Joseph Marasco, CEO of Chiral Quest. "This is a venture that will be welcomed by the chiral molecule marketplace, and will allow us to efficiently serve our growing client base."

Chiral Quest has wholly owned patents on a range of innovative chemical catalysts and processes used in the synthesis of chiral molecules. The company's primary laboratory and manufacturing facilities in New Jersey and China will now be supported by Sumitomo's extensive marketing capability and distribution network. Additional information on Chiral Quest is available at their website http://www.chiralquest.com/.

"Sumitomo has been a major supplier to the global pharmaceutical industry for over the past four decades," noted Yasunori Ishibashi, senior director of the SCOA Medical Sciences Group. "This collaboration makes it possible for Sumitomo to play a significant rol
'/>"/>

SOURCE Sumitomo Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
2. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
3. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
4. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
5. Chem Rx Corporation Reports Full Year 2007 Financial Results
6. Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results
7. Genaera Corporation Announces 2007 Financial Results
8. Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results
9. Immunosyn Corporation Announces 2007 Results, Files 10KSB
10. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
11. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... OXFORD, England and SAN JOSE, California ... an international biotechnology company developing antibody-drug conjugates for cancer, today ... its Board of Directors. Dr Reynolds has over 20 years, ... Chief Medical Officer at Seattle Genetics. "I am ...
(Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 2013 was ... Scottsdale’s Brain State Technologies®. They saw continued independent research ... Center who were awarded a $1 million grant from ... in “Brain and Behavior” a peer reviewed journal, Amy ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, 2014 ... Country Club, 1360 Almshouse Road, Warrington, Pa. , ... solely dedicated to finding a cure for hepatitis B and ... host its annual Crystal Ball on Friday, April 11 at ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... 18 Germany is on the,cutting edge in biotechnology ... production. Companies located in Germany are poised to,profit from ... an expert panel, at the BIO International Convention (BIO ... Germany co-chaired the,panel along with the CEO of a ...
... 18 Inverness Medical,Innovations, Inc. (Amex: IMA ... products for the consumer and professional markets, today,announced ... Russell, Vice,President, Finance, will attend the Jefferies 2nd ... York. Inverness, presentation is,scheduled for Wednesday, June 25 ...
... Synovics,Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a ... subsidiary,Kirk Pharmaceuticals, LLC (Kirk) during the past year ... list of clients that includes Target,Walgreens, Family Dollar, ... these retailers are all over-the-counter (OTC) private label ...
Cached Biology Technology:BIO 2008: Germany on Cutting Edge in Biomanufacturing 2Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 2Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 3Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 4Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 5
(Date:7/10/2014)... National Cancer Research Centre (CNIO) Macromolecular Crystallography Group ... protein called BuD to DNA in order to ... the researcher who led the study, says the ... the instructions contained in the genome to treat ... study is published in the journal Acta ...
(Date:7/10/2014)... control everyday household items such as washing machines could ... a new study has claimed., As part of an ... mathematicians, including those from the University of Exeter, have ... be replicated in the natural world to help restock ... - in essence a built-in feedback control mechanism to ...
(Date:7/10/2014)... Scientists at The University of Manchester are a step closer ... patients that undergo gastric bypass surgery. , The research, published ... likely to be explained by the actions of specialised cells ... when we eat. , During the research, the ... just one hormone, had up to six hormones including the ...
Breaking Biology News(10 mins):CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2Feedback control could be key to robust conservation management 2Scientists discover clues why weight-loss surgery cures diabetes 2
... a new type of 'bio-gel' which provides a pH neutral ... journal Advanced Materials (March 2006). , The gel is the ... of amino acids) to provide an environment in which cells ... mimics the properties of cell scaffolds which naturally occur in ...
... chemists have developed "self-exploding" microcapsules that could one day ... weeks or even months after injection. The study, by ... Louvain, is scheduled to appear in the Jan. 9, ... Biomacromolecules . , Unlike some other microcapsules, ...
... structures that are treated differently as a cell divides, UT ... could help lead to cancer therapies. , The study ... Cell ?focuses on the ends of DNA, which are capped ... telomeres shorten. When they become too short, the aging cell ...
Cached Biology News:Manchester scientists create new bio-gel for 3D cell culture 2DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... cell culture systems provide an integrated ... staining and imaging. Each system uses ... optical-quality coverslips in cell culture plates. ... and ready to use. Individual chambered ...
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Biology Products: